Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2307 (LINC02307)

Target
LINC02307
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

LINC02307 (long intergenic non-protein coding RNA 2307) is a human long intergenic non-coding RNA, distinguished as a member of the lincRNA family. LINC02307 does not encode a protein and is notable for its autonomous transcription from a genomic region that does not overlap any protein-coding genes[3][1][5]. Like other lincRNAs, it is implicated in the regulation of gene expression at the transcriptional and epigenetic levels, and may have enhancer-associated functions contributing to the modulation of neighboring gene activity[1]. While lincRNAs broadly have roles in human diseases—including cancer—the specific biological and disease-related functions of LINC02307 itself have not been reported or characterized in detail in current literature[3][1][5].

Other names
LINC02307Long intergenic non-protein coding RNA 2307
02

Mechanism of action

Not applicable, as no drugs targeting this RNA are documented.

03

Biological functions

Regulation of gene expression, including transcriptional and epigenetic regulationChromatin remodeling and genome architecture modulationPotential enhancer-associated activity (regulation of neighboring genes via sequence-independent mechanisms)
04

Disease associations

There is no explicitly documented disease association for LINC02307 in available sources. However, as lincRNAs as a class are involved in cancer and other diseases, it is possible members of this class may have roles yet to be discovered.Other
05

Safety considerations

Not applicable. No known therapeutic interventions or safety concerns have been documented for this RNA.
06

Interacting drugs

None documented. There are no known drugs that directly interact with LINC02307 or other lincRNAs individually.
07

Biomarkers

None documented for LINC02307 specifically.In general, some lincRNAs serve as biomarkers for cancer or other disease states, but there is no specific evidence for LINC02307.

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2307 (LINC02307).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2307 (LINC02307).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call